About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Advancing the Cholangiocarcinoma & Myeloid Lymphoid Neoplasm Patient Journey
Advancing the Cholangiocarcinoma & Myeloid Lymphoid Neoplasm Patient Journey
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
M
Importance of Molecular Profiling in Biliary Tract Cancer
By
Milind Javle
3 Videos
200 views
February 10, 2023
0 Comments
Login to view comments.
Click here to Login
Advancing the Cholangiocarcinoma & Myeloid Lymphoid Neoplasm Patient Journey
13:45
Flavio Rocha
How to Incorporate Molecular Testing in Therapy for Localized Cholan…
06:22
Milind Javle
Importance of Molecular Profiling in Biliary Tract Cancer
30:00
2023 Johns Hopkins Updates in Gastrointestinal Cancers
Managing Treatment-Related Side Effects in GI Cancers: Chemo, Target…
Feat.
P. Griffith
03:51
Moffitt Cancer Center
Real-World Characteristics, Treatment Patterns, and Outcomes of Pati…
Feat.
R. Kim
04:16
Moffitt Cancer Center
Real-World Use of Pemigatinib for Cholangiocarcinoma Among Racial an…
Feat.
R. Kim
08:24
ASH 2022 Conference Coverage
Phase 2 FIGHT-203 Study: Pemigatinib in Pts With Myeloid/Lymphoid Ne…
Feat.
A. Vannucchi
16:57
Scripps MD Anderson Cancer Center
What’s New: Oncology Drug Updates - Part 2
Feat.
B. Do
16:40
Moffitt Cancer Center
Year in Review: Hepatobiliary Cancers
Feat.
R. Kim,
T. Biachi
14:33
Insights from 2023 ESMO Annual Meeting
Personalized Medicine and Targeted Agents for Biliary Tract Cancer
Feat.
L. Rimassa
21:46
Insights from 2023 ESMO Asia Annual Meeting
ESMO Asia 2023 Insights: "Past, Present & Future Clinical M…
Feat.
M. Ikeda